Resource use and health outcomes with Penumbra’s tech were pitted against standard procedures such as anticoagulation, ...

Oppenheimer predicts growth for Penumbra Inc in MT market. Analyst initiates coverage with Outperform rating and $275 target ...

Oppenheimer initiated coverage of Penumbra (PEN) with an Outperform rating and $275 price target Penumbra is a leader in the mechanical ...

Penumbra, Inc. (NYSE:PEN) is a mid-sized medical device manufacturer headquartered in Alameda, California. The firm primarily makes and sells thrombectomy and embolization products. As of H1 2024 ...

In a report released today, Larry Biegelsen from Wells Fargo upgraded Penumbra (PEN – Research Report) to a Buy, with a price target of ...

a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise ...

We recently compiled a list of the Wells Fargo's Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth Estimates. In this article, we are going to take a look at where Penumbra, Inc.